Eli Lilly (NYSE: LLY) has partnered with the UK government, investing £279 million ($340 million) to address public health ...

TRIANA Biomedicines has entered into a strategic collaboration and licensing agreement with US pharma giant Pfizer to ...

Nuclera has raised $75 million, led by Elevage Medical Technologies, to commercialize its eProtein Discovery system. The ...

The US Food and Drug Administration (FDA) has approved Novocure's Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or ...

UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 ...

Johnson & Johnson has announced positive Phase II/III trial results for nipocalimab in generalized myasthenia gravis (gMG). The drug showed significant IgG reduction and sustained disease control.

Philadelphia, USA-based biopharma company Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners, with participation from ...

Amgen has reported positive Phase III results for Uplinza (inebilizumab-cdon) in treating generalized myasthenia gravis (gMG) ...

Commit Biologics has named Mikkel Wandahl Pedersen as CSO. Pedersen, with over 20 years in immuno-oncology, previously led ...

PharmaMar and Jazz Pharma positive top-line results from the Phase III clinical trial evaluating Zepzelca (lurbinectedin) in ...

Polish clinical-stage biotech Molecure has signed an exclusive licensing agreement with Ocean Biomedical based in Providence, ...

Novartis halted its Phase II IPF trial for LTP001, citing non-safety reasons. This move aligns with its strategy to ...